EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Diagnostic Accuracy of Fully Hybrid PET/MRI with [ 68 Ga]Ga-PSMA-11 and [ 68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard

Samuele Ghezzo, Paola Mapelli, Laura Lucia Cogrossi, Ana Maria Samanes Gajate, Giorgio Brembilla, Vito Cucchiara, Benedetta Mattorre, Tommaso Russo, Carolina Bezzi, Ilaria Neri, Sebastiano Vadalà, Andrea Alimonti und 7 weitere

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.125.269782 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Samuele Ghezzo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Edetic Acid, Oligopeptides, Positron-Emission Tomography. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The primary aim of this study was to compare the diagnostic accuracy of [68Ga]Ga-PSMA-11 PET, [68Ga]Ga-RM2 PET, and multiparametric MRI (mpMRI) for the detection of primary prostate cancer (PCa) using histopathology as the reference. The secondary aims of the study were to assess the agreement among imaging modalities and identify noninvasive biomarkers for the diagnosis and risk stratification of patients.

Methods

Forty-two patients with biopsy-confirmed, high-risk PCa were enrolled in this single-center, prospective, phase 2 clinical trial between September 2020 and May 2023 at San Raffaele hospital. All patients underwent [68Ga]Ga-PSMA-11 PET/MRI with mpMRI, and 36 had additional imaging with [68Ga]Ga-RM2 PET/MRI. All patients were included in the patient-level T staging analysis. Twenty-five patients were treated with radical prostatectomy with extended lymphadenectomy and considered for N staging analysis. Sixteen patients underwent all imaging and surgical procedures needed for coregistration between imaging and histology and were included in the lesion-based analysis for T staging. Two expert nuclear medicine physicians reviewed [68Ga]Ga-PSMA-11 and [68Ga]Ga-RM2 PET images with knowledge of the patients' available clinical and imaging information. mpMRI was interpreted as the standard of care by 2 expert radiologists using Prostate Imaging Reporting and Data System, version 2, criteria. Peripheral whole-blood samples were collected at the time of patient's enrollment to assess their association with lymph node involvement on histology.

Results

In the patient-based analysis, [68Ga]Ga-PSMA-11 PET and mpMRI identified at least 1 intraprostatic lesion in all patients, whereas [68Ga]Ga-RM2 PET results were negative in 3 of 36 patients. The lesion-level analysis performed in 16 patients showed that, in this cohort, the dominant intraprostatic lesion was always detected by [68Ga]Ga-RM2 PET, whereas both [68Ga]Ga-PSMA-11 PET and mpMRI missed it, reporting a false-positive finding elsewhere. For N staging analysis, [68Ga]Ga-PSMA-11 PET had the highest sensitivity among the investigated imaging modalities (sensitivity, 0.375). Blood analysis showed that a higher fraction of polymorphonuclear-myeloid-derived suppressor cells (MDSCs) over monocytic MDSCs was significantly associated patients with lymph node involvement on histology (P = 0.0285).

Conclusion

All imaging modalities showed high sensitivity for the preoperative detection of primary PCa, but only [68Ga]Ga-RM2 PET correctly identified the dominant lesion in all patients who underwent lesion-based subanalysis. The identification of lymph node involvement remains challenging, with [68Ga]Ga-PSMA-11 PET reaching a sensitivity of only 0.375. In this regard, the polymorphonuclear MDSC-to-monocytic MDSC ratio may represent a valuable biologic marker of lymph node involvement in patients with high-risk PCa and warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsEdetic AcidOligopeptidesPositron-Emission TomographyMagnetic Resonance ImagingMultimodal ImagingHumansMaleGallium RadioisotopesAgedMiddle AgedGallium IsotopesMultiparametric Magnetic Resonance ImagingReference StandardsProspective Studies

Stichwörter der Autor:innen

PET/MRIPSMARM2genitourinaryhistologyprostate cancer

Substanzen

gallium 68 PSMA-11Gallium RadioisotopesGallium IsotopesEdetic AcidOligopeptidesPSMA-11

Autor:innen und Institutionen

  • Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • Cellular Immunology Unit, Department of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele, Milan, Italy.
  • Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.

Zitieren

APA

Ghezzo, S., Mapelli, P., Cogrossi, L. L., Samanes Gajate, A. M., Brembilla, G., Cucchiara, V., Mattorre, B., Russo, T., Bezzi, C., Neri, I., Vadalà, S., Alimonti, A., Freschi, M., Briganti, A., De Cobelli, F., Chiti, A., Bellone, M., Scifo, P., & Picchio, M. (2025). Diagnostic Accuracy of Fully Hybrid PET/MRI with [ 68 Ga]Ga-PSMA-11 and [ 68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.269782

Vancouver

Ghezzo S, Mapelli P, Cogrossi LL, Samanes Gajate AM, Brembilla G, Cucchiara V, et al. Diagnostic Accuracy of Fully Hybrid PET/MRI with [ 68 Ga]Ga-PSMA-11 and [ 68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.125.269782

BibTeX
@article{Ghezzo2025,
  author = {Ghezzo, Samuele and Mapelli, Paola and Cogrossi, Laura Lucia and Samanes Gajate, Ana Maria and Brembilla, Giorgio and Cucchiara, Vito and Mattorre, Benedetta and Russo, Tommaso and Bezzi, Carolina and Neri, Ilaria and Vadalà, Sebastiano and Alimonti, Andrea and Freschi, Massimo and Briganti, Alberto and De Cobelli, Francesco and Chiti, Arturo and Bellone, Matteo and Scifo, Paola and Picchio, Maria},
  title = {Diagnostic Accuracy of Fully Hybrid PET/MRI with [ 68 Ga]Ga-PSMA-11 and [ 68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.125.269782}
}
Kostenlos starten →